A Better Diagnostic Tool for Brain Cancer, National Neurovision Research Institute (NNRI) Study

6/7/2012 7:56:39 AM

A joint study by researchers at the National Neuroscience Institute (NNI), National University of Singapore (NUS), and Singapore Institute for Clinical Sciences (SICS), A*STAR, has uncovered the role of a new tumour suppressor – known as parkin – in brain cancer that promises to shed insights into why certain brain tumours are more aggressive than others.

Read at MedicalXpress

Read Article at

Related Companies

News Categories

• MedicalXpress

• National Neurovision Research Institute (NNRI)

• Diagnostics

• Medical Dev. & Diag. - Research